Age Verification

Every customer must be 21 or older. Enforcement happens in three places:

1. On site. An age gate appears before any product content is shown, and the confirmation is remembered only on that device.
2. At checkout. Order data is reviewed before fulfilment. Orders that fail the age check are cancelled and refunded rather than shipped.
3. On wholesale. Retail accounts must be registered businesses, and we require confirmation that they enforce their own age policy at point of sale.

Product Status And Claims

Dopium products are sold as botanical products. They are not approved medicines and have not been evaluated by the Food and Drug Administration for any use. Nothing on this website is medical advice, and no Dopium product is intended to diagnose, treat, cure or prevent any disease.

We do not make disease claims, we do not market to anyone under 21, and we do not describe our products using withdrawal, detox or treatment language. If you see a reseller doing so with our packaging, that is not us and we would like to know about it.

Legal Status: What We Actually Know (Updated September 2026)

Here is the federal timeline, as of our last review, stated precisely because it is the part of this space that changes under you:

• Current federal status: 7-hydroxymitragynine is not federally scheduled in the United States as of this writing.
• July 29, 2025: the FDA formally recommended that the DEA place 7-OH in Schedule I. A recommendation begins a rulemaking; it is not itself a ban.
• July 6, 2026: the DEA published a notice of intent to temporarily schedule 7-OH above a specified concentration threshold in Schedule I, stating an order would be published in the Federal Register on or after August 5, 2026. A separate notice covered three synthetic, 7-OH-related compounds (mitragynine pseudoindoxyl, MGM-15, MGM-16).
• August 26, 2026: the temporary order covering those three synthetic compounds took effect. Products built on them are now Schedule I controlled substances federally.
• As of this writing: the temporary order covering concentrated 7-OH itself has not been published or taken effect. It can be published on any day and would take effect on publication.

The plain-language walk-through of this process is in the DEA 2026 scheduling explainer, and the buyer-side scenarios are in the what-happens-if-scheduled post. We update this section when the Federal Register moves.

States and provinces. Restrictions on kratom-derived products, including 7-OH, vary by U.S. state and Canadian province, and the landscape shifts repeatedly. We ship within the United States and Canada only, and we do not ship to jurisdictions where 7-OH is controlled or prohibited. We do not maintain a published blocked-jurisdiction list at this time, and placing an order means you have confirmed that the product is lawful to possess where you live. If you are unsure, check with your state or provincial authorities before ordering. The U.S. state overview and the Canada guide explain the landscape; the current order is your confirmation, and orders we cannot lawfully fulfil are cancelled and refunded.

Canada

We accept orders from Canada. Customers should be aware that Health Canada has not approved kratom or kratom-derived alkaloids for human consumption, and products of this type are not authorised as natural health products in Canada. Ordering from outside the United States is your decision to make with that understood, and import decisions rest with you and with the Canada Border Services Agency.

Safe Use

Reporting A Problem

If you experience an adverse event, stop using the product and contact us with your batch code. We log adverse reports against the batch and escalate to the testing laboratory where a pattern emerges. If you are in the United States you can also report to the FDA’s MedWatch programme. The emergency resources are in the emergency page.

Batch verification   Full FAQ   Terms of service